扫码关注公众号           扫码咨询技术支持           扫码咨询技术服务
  
客服热线:400-901-9800  客服QQ:4009019800  技术答疑  技术支持  质量反馈  人才招聘  关于我们  联系我们
产品中心-北京博奥森生物技术有限公司
Recombinant SARS-Cov-2 Spike S1 protein (69/70 deletion, 144Y deletion, N501Y, A570D, D614G, P618H, hFc-(100-330aa), hFc (HEK293) (bs-41455P)  
订购热线:400-901-9800
订购邮箱:sales@bioss.com.cn
订购QQ:  400-901-9800
技术支持:techsupport@bioss.com.cn
说明书: 100ug  500ug  
100ug/4880.00元
500ug/15800.00元
大包装/询价

产品编号 bs-41455P
英文名称 Recombinant SARS-Cov-2 Spike S1 protein (69/70 deletion, 144Y deletion, N501Y, A570D, D614G, P618H, hFc-(100-330aa), hFc (HEK293)
中文名称 重组SARS冠状病毒2 Spike突变蛋白S1(69/70 deletion,144Y deletion,N501Y, A570D, D614G, P618H)
别    名 SARS-CoV-2 spike protein; 2019-nCOV Spike protein; Spike glycoprotein; Spike protein S1; Surface glycoprotein; Spike protein RBD; SPIKE_SARS2; 2019-nCOV Spike S1(69/70 deletion,144Y deletion,N501Y, A570D, D614G, P618H), Recombinant (hFc Tag); Recombinant SARS-Cov-2 Spike S1 protein (69/70 deletion, 144Y deletion, N501Y, A570D, D614G, P618H, hFc-(100-330aa), hFc (HEK293)  型新冠蛋白; 新冠病毒S蛋白突变体(69/70 deletion,144Y deletion,N501Y, A570D, D614G, P618H); 重组新冠病毒 Spike突变蛋白S1(69/70 deletion,144Y deletion,N501Y, A570D, D614G, P618H); 新型冠状病毒Spike突变体蛋白.
理论分子量 103kDa
检测分子量 150-180
性    状 Lyophilized or Liquid
浓    度 >0.5 mg/ml
物    种 SARS-Cov-2
序    列 14-685/1273
纯    度 >95% as determined by SDS-PAGE
纯化方法 AC
内毒素 Not analyzed
表达系统 HEK293 cell
活性 Yes
标签 hFc
缓 冲 液 PBS (pH7.4).
保存条件 Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles.
注意事项 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍 The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SWISS:
P0DTC2

Gene ID:
43740568

产品图片
The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
版权所有 2004-2026 www.bioss.com.cn 北京博奥森生物技术有限公司
通过国际质量管理体系ISO 9001:2015 GB/T 19001-2016    证书编号: 00124Q34771R2M/1100
通过国际医疗器械-质量管理体系ISO 13485:2016 GB/T 42061-2022    证书编号: CQC24QY10047R0M/1100
京ICP备05066980号-1         京公网安备110107000727号